Stimulation of pS2 expression by diet-derived compounds.

Epidemiological studies suggest a lowered risk of hormone-dependent cancers among vegetarians, but the basis for this association remains unclear. Vegetables and fruits contain certain compounds which can be converted to biologically active hormone-like substances, such as lignans and isoflavones, by intestinal flora. The interaction of these compounds with endogenous hormones may be a novel, diet-dependent mechanism in cancer prevention. To explore this possibility, we developed a rapid, specific assay system to screen for compounds with estrogen-like activity in tissue culture. We utilized the estrogen receptor-positive breast cancer cell MCF-7 and monitored the expression of the estrogen-responsive protein pS2 by Northern blots. Our results indicated that the phenolic compounds daidzein, equol, nordihydroguaiaretic acid, enterolactone, and kaempferol were able to elicit an estrogen-like response, while quercetin and enterodiol were not.

[1]  J. E. Dunn.  Cancer epidemiology in populations of the United States--with emphasis on Hawaii and California--and Japan. , 1975, Cancer research.

[2]  W. McGuire,et al.  Phytoestrogen interaction with estrogen receptors in human breast cancer cells. , 1978, Endocrinology.

[3]  L. C. Anderson,et al.  LIGNAN FORMATION IN MAN—MICROBIAL INVOLVEMENT AND POSSIBLE ROLES IN RELATION TO CANCER , 1981, The Lancet.

[4]  R. Farrant,et al.  Chemical synthesis of the first lignans to be found in humans and animals , 1981 .

[5]  S. Sonoda,et al.  Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor. , 1982, Gan.

[6]  M. Thibier,et al.  Identification and quantitative estimation of a lignan in human and bovine semen. , 1982, Journal of reproduction and fertility.

[7]  S. Yamamoto,et al.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor. , 1982, Cancer research.

[8]  J. Dwyer,et al.  EXCRETION OF THE LIGNANS ENTEROLACTONE AND ENTERODIOL AND OF EQUOL IN OMNIVOROUS AND VEGETARIAN POSTMENOPAUSAL WOMEN AND IN WOMEN WITH BREAST CANCER , 1982, The Lancet.

[9]  R. Farrant,et al.  The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine. , 1982, The Biochemical journal.

[10]  A. Waters,et al.  Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. , 1982, Journal of reproduction and fertility.

[11]  P Chambon,et al.  Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. , 1984, Nucleic acids research.

[12]  P. Chambon,et al.  Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Bates,et al.  Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. , 1988, Molecular endocrinology.

[14]  U. Mayr.  Estrogen‐controlled gene expression in tissue culture cells by zearalenone , 1988, FEBS letters.

[15]  P. Chambon,et al.  Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P Chambon,et al.  The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c‐Ha‐ras oncoprotein and the c‐jun protein. , 1989, The EMBO journal.

[17]  H. Rochefort,et al.  Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. , 1989, Molecular endocrinology.

[18]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[19]  H. Adlercreutz,et al.  Phytoestrogens: new ligands for rat and human alpha-fetoprotein. , 1991, Biochimica et biophysica acta.

[20]  B. Katzenellenbogen,et al.  Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines. , 1991, Molecular endocrinology.

[21]  H. Adlercreutz,et al.  Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. , 1991, The American journal of clinical nutrition.

[22]  L. Rothblum,et al.  Rapid, small-scale RNA isolation from tissue culture cells. , 1991, BioTechniques.

[23]  F. Menn,et al.  The estrogenic activity of certain phytoestrogens in the siberian sturgeon Acipenser baeri , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  O. Yoshida,et al.  Anti‐promoting Effect of Nordihydroguaiaretic Acid on N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine and Sodium Saccharin‐induced Rat Urinary Bladder Carcinogenesis , 1992, Japanese journal of cancer research : Gann.

[25]  U. Mayr,et al.  Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. , 1992, Toxicology.

[26]  H. Adlercreutz,et al.  Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  Herman Adlercreutz,et al.  In vitro bioassays of non-steroidal phytoestrogens , 1993, The Journal of Steroid Biochemistry and Molecular Biology.